Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Financials
52W LOW $18.5552W HIGH $36.83
Volume
1.19 M
Value Traded
33.28 M
Short % Float
2.68%
+4.69%Week
+8.06%1 Month
+16.59%3 Month
+64.98%6 Month
Cash Data
- Monthly Burn
- Burn Trend
- Dilution Risk
- SEC Filing
Key Stats
Market Cap
4.67 B
EPS (TTM)
1.56
P/E Ratio
23.49
Ent. Value
4.51 B
Total Shares
127.52 M
Float Shares
118.61 M
Insiders
6.99%
Institutions
88.10%
Upcoming Catalysts
FDA decisions, readouts and PDUFA dates · scored by probability of approval
| Catalyst | Drug / Treatment | Stage | Prob. of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | Small Molecule | Oncology | - |
PoA blends historical approval base rates, trial design score and FDA review track record.
CON Catalyst Timeline
Dated clinical, regulatory and corporate events for Concentra Group Holdings Parent, Inc.
Catalyst Timeline
Dated clinical, regulatory & corporate events for Concentra Group Holdings Parent, Inc.
2Total events
0Upcoming
0Tier-1 (high impact)
2026 to 2026Coverage
Past FDA Catalysts and PDUFA Decisions
How CON actually traded into and out of each decision
| Date | Drug | Catalyst | Stage | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|
| - | Example Drug | Phase 3 data readout | Phase 3 |
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision
Drug Pipeline Intelligence
No drug pipeline
Concentra Group Holdings Parent, Inc. is a services and tools company (CRO, lab tools or healthcare services). The clinical trials it takes part in test other companies' drugs, so it has no drug pipeline of its own to score.
Clinical Trial Results
Readouts, endpoints and source filings for every CON program
Inside Trades
| Insider | Side | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| ORTENZIO ROBERT ADirector | Sell | -130,000 503,455 held | $31.84 | 08/03/2026 |
Hedge Fund 13F Activity
Hedge Funds invested in CON
| Fund | % of Portfolio | Current MV | Shares Owned | Activity |
|---|---|---|---|---|
| PROSIGHT MANAGEMENT, LP | 1.8 % (-50 %) | 10.85 M | 505.82 K | -43.23% ( -385.21 K) |
CON Institutional Ownership Trends
Options Data
Option Volume
Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg
Option Chain Statistics
| Expiry | Call Vol | Put Vol | Vol P/C | Call OI | Put OI | OI P/C | IV Call | IV Call OI-Wtd | IV Call Vol-Wtd | IV Put | IV Put OI-Wtd | IV Put Vol-Wtd |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-20 | ||||||||||||
Real-Time Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last | Vol | OI | Last | Vol | OI | |
| No data available | ||||||
Calls vs Puts by Expiry
CallsPutsLog scale
Competitive positioning
How CON ranks across every disease it competes in
Competitive Position is a premium feature
See how CON ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trialCON News
-CON
Oct 8, 2026▲ +0.6%today
Concentra to Announce Third Quarter 2026 Results on Thursday, November 5, 2026
Concentra Group Holdings Parent, Inc. will announce its third quarter financial results for 2026 on November 5, 2026. Following the announcement, a conference call is scheduled for November 6, 2026, at 9 a.m. Eastern Time. This call will be accessible via a live webcast, promoting investor engagement.
Read more →-CON
Sep 14, 2026Concentra Expands Florida Footprint with New Daytona Beach Medical Center
Concentra has opened a new medical center in Daytona Beach, Florida, marking its first location in Volusia County. This facility aims to improve access to occupational health services for both employers and employees in the Greater Daytona region. The center's strategic location at key transportation corridors is expected to enhance its service reach.
Read more →-CON
Sep 8, 2026Concentra Appoints Tanner Newton Chief Financial Officer
Concentra has appointed Tanner Newton as its new Chief Financial Officer, effective November 1, 2026. Newton, currently the senior vice president of strategy and finance, will report to Matt DiCanio, who is transitioning to president and CEO on the same date. This leadership change is part of Concentra's strategy for continued growth in occupational medicine.
Read more →-CON
Aug 18, 2026Concentra Appoints Dr. Jill Rosenthal as Chief Medical Officer to Advance Clinical Innovation and Workforce Health
Concentra has appointed Dr. Jill Rosenthal as Chief Medical Officer, effective January 1, 2027. Dr. Rosenthal, who has previously held leadership roles at Concentra, will oversee the company's national clinical strategy and physician leadership. Her extensive experience in occupational medicine positions her to drive clinical innovation within the organization.
Read more →-CON
Aug 17, 2026Concentra Strengthens Workforce Health Access in Minnesota Through Acquisition
Concentra has completed the acquisition of four Minnesota Occupational Health medical centers, enhancing access to specialized occupational health care for employees in the Twin Cities. This move allows local care teams to leverage Concentra's national clinical and operational resources, improving workforce health services in the region. The acquisition is effective from August 17.
Read more →-CON
Aug 10, 2026Concentra to Present at Upcoming Investor Conferences
Concentra Group Holdings Parent, Inc. has announced its participation in several upcoming investor conferences, including the Bank of America Virtual SMID Cap Conference and the Wells Fargo Healthcare Conference. This engagement highlights the company's position as a leading provider of occupational health services in the U.S. The conferences are scheduled for August and September 2026.
Read more →-CON
Aug 6, 2026▲ +11.5%on this newsshared move
Concentra Group Holdings Parent, Inc. Announces Results For Its Second Quarter Ended June 30, 2026 and Raises FY 2026 Guidance
Concentra Group Holdings Parent, Inc. reported strong financial results for the second quarter of 2026, highlighting a revenue increase of 10.0% and a significant net income growth of 46.5%. The company also saw a 22.5% rise in Adjusted EBITDA. Additionally, Concentra raised its full-year guidance for 2026, signaling positive expectations for the remainder of the year.
Read more →-CON
Jul 20, 2026Concentra Expands into Idaho with Opening of Boise Medical Center
Concentra has announced the opening of its first medical center in Idaho, located in Boise. This expansion aims to improve access to occupational health services for employers and employees in the region. The center is situated in Federal Way Plaza, making it easily accessible for the local workforce.
Read more →-CON
Jul 13, 2026Concentra Expands Near Kansas City International Airport with New Medical Center
Concentra has announced the opening of a new medical center in Kansas City, Missouri, aimed at enhancing access to occupational health services. This facility is strategically located near the Kansas City International Airport, catering to the needs of the local workforce. The expansion reflects Concentra's commitment to providing specialized health services in a growing business hub.
Read more →-CON
Jul 9, 2026Concentra to Announce Second Quarter 2026 Results on Thursday, August 6, 2026
Concentra Group Holdings Parent, Inc. will announce its financial results for the second quarter of 2026 on August 6, 2026. The announcement will occur after market close, followed by a conference call on August 7, 2026, at 9 a.m. ET. Stakeholders can access the call via a live webcast.
Read more →-CON
Jun 24, 2026Concentra Expands Arizona Presence with New Goodyear Medical Center
Concentra has announced the opening of a new medical center in Goodyear, Arizona. This expansion aims to enhance healthcare access in the region. The new facility will provide a range of medical services to the local community.
Read more →-CON
May 7, 2026Concentra Group Holdings Parent, Inc. Announces Results for Its First Quarter Ended March 31, 2026, Cash Dividend, and Raised FY 2026 Guidance
Concentra Group Holdings Parent, Inc. announced its results for the first quarter ending March 31, 2026. However, the article provides minimal details about the financial performance or the specifics of the cash dividend and raised guidance. Overall, the lack of information limits the understanding of the company's current status.
Read more →-CON
Apr 14, 2026Concentra Chief Medical Officer Dr. Anderson to Retire After 33 Years
Dr. Anderson, the Chief Medical Officer of Concentra, has announced his retirement after 33 years of service. His departure signifies a significant transition for the company, which may encounter difficulties in leadership continuity. The impact of his retirement on Concentra's future operations remains to be seen.
Read more →-CON
Jun 2, 2025Concentra Announces Closing of Pivot Onsite Innovations Acquisition
Concentra Group Holdings Parent, Inc. has closed the acquisition of Pivot Onsite Innovations from Athletico Physical Therapy for $55 million. This acquisition significantly enhances Concentra's onsite health segment, doubling its size and expanding its reach to approximately 350 health clinics across over 40 states. The integration aims to improve service offerings for large employers while maintaining high-quality clinical care. Key leadership from Pivot will transition to Concentra to ensure continuity and growth for the newly expanded organization.
Read more →-CON
Mar 31, 2025Concentra Announces Signing of Definitive Agreement to Acquire Pivot Onsite Innovations
Concentra Group Holdings has signed a definitive agreement to acquire Pivot Onsite Innovations, a leader in onsite health services. This strategic move aims to enhance Concentra's service offerings, effectively doubling the capacity of its Onsite Health division. Key leaders from Pivot are set to transition into Concentra to ensure continuity. The transaction is valued at $55 million, with expectations to close in Q2 2025, subject to customary conditions.
Read more →-CON
Jan 22, 2025Concentra Announces Preliminary 2024 Financial Results, Agreement To Acquire Nova Medical Centers, and 2025 Financial Guidance
Concentra has announced its preliminary financial results for 2024, along with plans to acquire Nova Medical Centers, enhancing its occupational health services. The acquisition is valued at $265 million and aims to improve access to healthcare for employers. Concentra's positive 2025 guidance reflects strong business performance from the previous year. The deal is anticipated to close in the first quarter of 2025, subject to standard regulatory approvals.
Read more →-CON
Nov 12, 2024xA9;2024 Concentra Inc. All rights reserved. Investor Presentation November 2024 ©2024 Concentra Inc. All rights reserved. Disclaimer 2 Forward-Looking Statements This presentation contains forward-looking statement
Concentra Inc. presented an overview of its recent performance and leadership structure during its November 2024 investor presentation. The company, which operates the largest network of occupational health services in the U.S., reported a modest year-to-date revenue increase. The presentation emphasized the extensive experience of its leadership team in healthcare and their commitment to improving worker health. No specific risks or negative projections were detailed in the information provided.
Read more →-CON
Oct 31, 2024Concentra Group Holdings Parent, Inc. Announces Results For Its Third Quarter Ended
Concentra Group Holdings Parent, Inc. reported positive results for its third quarter ended September 30, 2024, demonstrating a revenue increase of 3.3% compared to the prior year. The company's income from operations increased by 6.5%, reflecting solid execution and strategic progress, including successful separation from Select Medical. Additionally, Concentra declared a cash dividend of $0.0625 per share, payable on November 22, 2024. The leadership expressed confidence in achieving their business objectives and anticipates continued growth moving forward.
Read more →-CON
Aug 1, 2024Concentra Group Holdings Parent, Inc. Announces Results For Its Second Quarter Ended
Concentra Group Holdings Parent, Inc. announced its second quarter results for 2024, showing a revenue increase of 2.3% to $477.9 million despite a decrease in net income and earnings per share. The company completed a successful initial public offering, raising $528.8 million, while patient visits dropped slightly compared to the previous year. Concentra continues to expand its facilities, now operating 547 occupational health centers and 154 onsite clinics, emphasizing its commitment to improving workforce health.
Read more →About Concentra Group Holdings Parent, Inc.
Headquarters5080 SPECTRUM DRIVE, ADDISON, TX, 75001
BIOPHARMAWATCH ELITE PLUS
Trade the next CON catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $19/mo billed annually.
Cancel anytime